Even the very earliest articles describing the effectiveness of imipramine dimethylaminopropyl-iminodibenzyl hydrochloridet in the treatment of depression reported cardiovascular secondary effects (2, 5, 10) . The onset or exacerbation of cardiovascular complications was attributed to the use of the drug. The conclusions were drawn that it is not entirely safe to use imipramine in the presence of pre-existent heart disease (8, 9) . Although serious myocardial involvement is seldom encountered as a side effect, there have been a few documented cases of acute myocardial infarction associated with this drug (4, 5, 6, 7, 12) . Most of these were in patients with pre-existing cardiovascular pathology. In all cases patients were receiving average or higher doses of the drug (75-300 mg. daily) for periods ranging from several days to several months before the onset of symptoms attributable to the heart. Presented here is a case of myocardial infarction which followed two days of imipramine therapy at subclinical dose levels.
Report of a Casett
A 61-year old male shipping clerk was admitted to the hospital with a three-day history of left-sided weakness. The patient had been under observation for two years for essential hypertension and was managed at present on a low salt diet and hydrochlorothiazide. He had been doing relatively well until three days prior to admission when he developed sudden weakness of the left side of the body and inability to walk. There was no dysarthria, headache, convulsion, syncope or visual disturbance. He had a long-standing history of mild exertional dyspnea and moderate obesity. There was no history of angina pectoris, cardiac decompensation or myocardial infarction. There was no record of previous hospitalization. *MaRuscript received September, 1968. 'Vellow in child and adolescent psychiatry, Bellevue Hospital Center, New York.
tTofraniI. ttThe case reported was under the author's care while an intern at Beekman-Downtown Hospital, New York City.
Canad. Psychiat. Ass. J. Vol. 14 (1969) Physical examination of the patient revealed a moderately obese, middle-aged man. His pulse was 84 and regular, blood pressure 188/100 and respirations 22. A left-sided hemiparesis was noted. Accentuated deep tension reflexes and a positive Babinski sign were found on the left side. The remainder of the findings were within normal limits.
The CBC, urine analysis, FBS, BUN, Electrolytes, lumbar puncmre, chest and skull radiograms were all within normal limits. An electrocardiogram was normal. An electroencephalogram showed a right temporalparietal focus of abnormality. The clinical diagnosis was cerebral vascular incident, right cerebral thrombosis.
While it was felt that the patient's clinical course was proceeding as well as could be expected, he himself became increasingly depressed and inert. He wept on occasion and became childishly demanding and petulant during the third week of convalescence.
O~the sixteenth hospital day the patient was started on 10 mg. of imipramine T.ID. On the evening of the following day he complained of severe substernal pain and dyspnea. Blood pressure was 140170 and pulse 160 and regular. An electrocardiogram taken at the bedside revealed rapid sinus tachycardia and diminished R wave voltage in V 5-6. It was felt that the clinical picture was suggestive of an acute lateral wall myocardial infarction. The patient was treated with morphia and oxygen, and imipramine was discontinued. The SGOT was 51, the LDH was 1070. The next morning an electrocardiogram showel rapid sinus tachycardia and persistent diminished R waves in V 5-6. Later in the day, another tracing showed replacement of the R wave in V -5 by a Q-S complex, strongly suggesting that a lateral wall infarction had occurred. The SGOT was 80, the LDH was 1420. The patient expired the following morning.
Discussion
Imipramine is one of the most widely used drugs for the treatment of depression. It may be considered a successor to the MAO inhibitors which for years represented the only pharmacologic approach. This drug differs from the phenothiazines only by the replacement of the sulfur with an ethylene linkage. The most common side effects include atropine-like reactions such as xerostomia, blurred vision, tachycardia, constipation and delayed micturition. The more serious secondary effects are postural hypotension, increased intraocular tension, jaundice, urinary retention, toxic confusional states and hypopyrexia. Infrequently encountered but hazardous cardiovascular complications have included electrocardiographic changes ranging from reversible nonspecific T wave changes and prolongation of the P-R interval to atrial and ventricular arrhythmias and acute myocardial infarction (1, 4, 9) . The few reported cases of the latter were for the most part in those with serious preexistent heart disease. An exception to this is a case reported by Sloman in which the patient was young and healthy, presumably without previous cardiac impairment. In that case, however, the patient had undergone subcoma insulin therapy which may have precipitated the infarction (12) .
In all previously reported cases, the patients received at least 75 mg. of imipramine daily, 'Usually incremented to daily doses of 200-300 mg. In addition the drug was taken for periods of several days to several months before myocardial infarction developed.
A Note on the Cardiovascular Pharmacology of Imipramine
The heart muscle has an affinity for imipramine. Following a single intravenous dose the largest concentrations are found in the brain and kidney tissue. The third largest concentration is found in the heart (3).
This drug exerts a dual action on the cardiovascular system. Small doses are known to exert a positive inotropic and positive chronotropic effect, thereby raising blood pressure. Larger doses reduce cardiac contractility and rate, thereby lowering blood pressure. Injec-tion of small doses sensitizes adrenergic receptors to norepinephrine. In this respect imipramine resembles cocaine. Small doses actually increase coronary arterial flow. Higher doses reduce coronary flow, presumably due to diminished cardiac output. This drug is known to obtund various cardiovascular reflexes such as the carotid occlusion reflex and the Bezold-Jarisch reflex-vasomotor reflexes originating from receptors in the ventricles, aorta, and lungs (11) .
